Overview
ENA (ENA) and Injective (INJ) sit at different layers of the crypto stack. At current prices ($0.089200 vs $5.08), market leadership still favors ENA on capitalization, while 24h tape is led by ENA.
Quick winners
Full comparison
| Metric | ENA | INJ |
|---|---|---|
| Price | $0.089200 | $5.08 |
| Market Cap | $852.44M | $490.41M |
| FDV | — | — |
| Volume 24h | $19.18M | $2.27M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 75.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ENA | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +10.67% | +4.65% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ENA | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 63.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Relative technical health favors reading both charts side by side. AI scores (58.40 vs 47.50) summarize PEPS modules, but supports and resistances still decide invalidation.
Fundamentals
| Metric | ENA | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
ENA
Injective
Pros and cons
Pros of ENA
- Higher ranking for ENA can translate into tighter spreads on major venues.
- Composite PEPS readings for ENA can surface clearer module agreement during trend phases.
- ENA typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- ENA has an established coin page footprint on PEPS for continuous monitoring.
Cons of ENA
- Large-cap status for ENA can mean slower percentage upside versus high-beta alternatives.
- Regulatory or macro headlines can hit ENA harder simply because it is more visible.
- Crowded positioning around ENA sometimes amplifies squeeze or flush risk.
Pros of Injective
- Diversifying versus ENA with Injective can change portfolio factor exposure.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- If technical momentum aligns, Injective may outperform on medium-term windows.
Cons of Injective
- Trend failures on Injective often travel faster than on more established assets.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Smaller book depth versus large caps can increase slippage for Injective.
Which looks stronger right now?
If you weight capitalization and liquidity, ENA looks sturdier; if you weight 24h tape, ENA is ahead. A balanced view treats both as incomplete signals.
AI summary
This AI-assisted summary starts from live PEPS fields. ENA holds market-cap $852.44M and rank #75; Injective shows $490.41M and #99. Where liquidity and flow matter, watch ENA. Where durability matters, watch ENA. AI composite scores (58.40/47.50) compress those tensions into a single lens. In probabilistic terms, the side winning more columns may have a nearer-term edge, but tails remain fat. Revisit after the next hourly refresh.
FAQ
Which is better, ENA or Injective?
“Better” depends on horizon and risk. ENA leads on market cap today, while ENA leads the 24h move — neither is a guarantee.
Which has more upside potential, ENA or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both ENA and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. ENA currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is ENA, but longer windows can disagree.